Skip to content

Improving Muscle Assessment in Older Adults - The Can We Build a Better Mouse Trap? Study

Improving Muscle Assessment in Older Adults - The Can We Build a Better Mouse Trap? Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02295241
Enrollment
112
Registered
2014-11-20
Start date
2015-02-28
Completion date
2015-10-31
Last updated
2016-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Keywords

Sarcopenia, muscles, aging

Brief summary

The primary aim of this study is to compare traditional muscle function tests with computerized versions using body-worn motion sensors and video motion analysis of the same tests. The investigators selected the Timed Up and Go (TUG) test as the investigators primary variable for this aim with several other function tests (e.g., repeated chair rise, 6-meter walk, 2-minute walk, Romberg stance, semi-tandem / tandem stance) as secondary variables. The investigators primary hypothesis is that the computerized versions of the TUG test are highly correlated (\>0.9) with the traditional method, but with comparable or better reproducibility. Secondary analyses will correlate other function tests with their computerized version, again with the hypothesis that they are highly correlated and that computerized versions are of similar or better reproducibility. This analysis will also compare traditional assessments of balance with a computerized balance method, computerized dynamic posturography.

Interventions

OTHERNo intervention

This is an observational trial, no interventions are being used.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Ambulatory, community dwelling men and women age ≥ 70 years 2. Able and willing to sign informed consent 3. Able to stand without assistance

Exclusion criteria

1. History of myocardial infarction within the prior six months or ongoing angina 2. History of injury or surgery within the prior six months which limits the ability to ambulate 3. History of malignancy with metastasis to the musculoskeletal system 4. Neuromuscular disease or severe end organ disease impairing balance or muscle function to the degree that completion of all study tests is unlikely.

Design outcomes

Primary

MeasureTime frameDescription
The comparison of results of traditional physical function tests with the results of computerized versions (body worn sensors and Kinect system) of the same tests.All physical function tests will be performed at the first visit and visit 2 up to 4 days laterShort-term reproducibility of traditional vs. computerized functional tests will also be compared.

Secondary

MeasureTime frameDescription
Explore the capabilities of the Microsoft Kinect system to record and analyze muscle function tests and correlate the Microsoft Kinect system to a gold standard motion analysis system.All physical function tests will be performed at the first visit and visit 2 up to 4 days later.
Validate the use of BIS (Bioelectrical Impedance Spectroscopy) to adjust DXA (Dual Energy X-ray Absorptiometry) -measured body composition by providing muscle mass measurementBIS is performed at visit 1 and visit 2 up to 4 days later. DXA is performed at visit 2.The relationship of lean mass, as estimated by DXA and BIS with muscle mass as measured by deuterated creatine dilution as a nominal gold standard. Additionally, the correlation of lean mass as measured by DXA and muscle mass as measured by BIS and creatine dilution with muscle function tests.
Correlate various ratios of lean or muscle mass / DXA measured fat mass with functional tests.All physical function tests will be performed at the screen and follow up visits.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026